Connotea: rjharrison's bookmarks matching tag mit

rjharrison's tags:

Find:

Abraxis Bioscience

Acacia Technologies

accelerated examination

Application Programming Interface

Ariad Technologies

Atotech Deutschland

Barr Pharmaceuticals

Brilliant Digital

Business Method Patents

Cambridge Antibody Technology

carbon nanotube

Computer Implemented Inventions

Content Distribution Networks

Contractual Law

Cross Atlantic Capital

Essential Patent

European Chamber of Commerce in China

European commission

European Court of Justice

european parliament

European Patent Convention

European Patent Office

Framework Programme

French Language

Guidelines for Examination

Integran Technologies

Intellectual Asset Management

intellectual property

intellectual property rights

Intellectual Ventures

International Patent Classification

International Trade Commission

Inventor Compensation

knowledge economy

London Agreement

Médicins sans Frontières

Medicine sans Frontières

Mobile Entertainment Forum

Mobile Telecommunications

National Nanotechnology Initiative

Patent Annuities

Patent Application

Patent Classification

Patent Cooperation Treaty

Patent Infringement

Patent Licensing

Patent Litigation

Patent Prosecution

Patent Revocation

Patent Valuation

Royal Academy of Engineering

Software Protection

State Street Bank

Technical Board of Appeal

technology transfer

telecommunications

titanium dioxide

Trademark Infringement

TrueNames Patent

University Texas

Variable Valve Timing

venture capital

Users who used mit:

K_A_I_L_E_S_- H

EXPORT LIST

rjharrison's bookmarks matching tag mit

Number of articles per page:

10 | 25 | 50 | 100

Patent Baristas » Print » Can a Known Drug Infringe a Later Issued Patent on the Pathway of Action? A Jury Says Yes.

www.patentbaristas.com

Posted by rjharrison to Ariad Technologies MIT harvard XIGRIS evista Eli Lilly on Sun Sep 09 2007 at 05:39 UTC | info | related

<< Prev 0 Showing entries 1 to 1 of 1 total Next 0 >>